biomedicina slovenica

"Glioblastom" : 209

  1. Jovchevska Ivana
    Uporaba kamelidnih nanoteles v raziskavah glioblastoma
    2022 ►
  2. Zottel Alja; Colja Sara; Šamec Neja; Romih Rok; Jovchevska Ivana
    Sonication-packed anti-vimentin nanobody in glioblastoma exosomes shows decreased survival of glioblastoma stem cell line NCH421k
    2022 ►
  3. Jovchevska Ivana; Šamec Neja; Zottel Alja; Katrašnik Mojca; Krapež Gloria; Kump Ana; Šribar Jernej; Križaj Igor; Stojan Jure; Muyldermans Serge; Bajc Gregor; Butala Matej
    Functional validation of Α-FREM2 nanobody shows potential to specifically target glioblastoma stem cells in vitro
    2022 ►
  4. Krapež Gloria; Katrašnik Mojca; Šamec Neja; Zottel Alja; Jovchevska Ivana
    Examining the changes in FREM2 gene and protein expression in glioblastoma cells in the presence and absence of temozolomide
    2015 ►
  5. Jovchevska Ivana
    Transcriptome profiling of long- and short-term glioblastoma survivors revealed overexpression of LNCRNA CRNDE as a prognostic biomarker of poor survival
    2022 ►
  6. Žugec Maja; Potokar Maja
    Experimental models for studying migratory potential of astrocytes
    2022 ►
  7. Žužek Zala; Bolčina Lara; Kump Ana; Jovchevska Ivana
    Repozicioniranje zdravil
    [Drug repurposing]
    2022 ►
  8. Knez Lea; Krivec Eva; Zottel Alja; Šamec Neja
    Imunoterapija pri zdravljenju glioblastoma
    [Immunotherapy in the treatment of glioblastoma]
    2022 ►
  9. Krapež Gloria; Kouter Katarina; Jovchevska Ivana; Videtič Paska Alja
    Dynamic intercell communication between glioblastoma and microenvironment through extracellular vesicles
    2022 ►
  10. Zottel Alja; Jovchevska Ivana; Šamec Neja; Kump Ana; Dall’Olio L. Rapor; Pužar Dominkuš Pia; Romih Rok; Hudoklin Samo; Mlakar Jernej; Nikitin D.; Sorokin M; Buzdin Anton A.; Komel Radovan
    VIM, miR-124-3p and miR-9-5p areoverexpressed in small extracellular vesicles ofglioblastoma cells
    2021 ►
  11. Jovchevska Ivana; Šamec Neja; Zottel Alja; Muyldermans Serge; Šribar J.; Križaj Igor; Stojan Jure; Komel Radovan
    Selective targeting of glioblastoma stem cells with camelid [alpha]‐FREM2 nanobody
    2021 ►
  12. Jovchevska Ivana; Šamec Neja; Zottel Alja; Mlakar Jernej; Porčnik Andrej; Muyldermans Serge; Myers M. P.; Eyer J.; Lah Turnšek Tamara; Komel Radovan
    Attempts to develop nano-targeting of glioblastoma stem cells
    2021 ►
  13. Šamec Neja; Jovchevska Ivana; Zottel Alja; Novak Matjaž; Prosenc Zmrzljak Uršula; Košir Rok; Mali Polonca; Železnik Klara; Skoblar Vidmar Marija; Gregorič Kramberger Milica
    Identification of novel glioblastomabiomarkers for non-invasive liquid biopsy
    2021 ►
  14. Jovchevska Ivana; Šamec Neja; Zottel Alja; Kump Ana; Muyldermans Serge; Šribar Jernej; Križaj Igor; Stojan Jure; Bajc Gregor; Butala Matej
    Carmelid [alpha]-FREM2 nanobody decreases proliferation of glioblastoma stem cells and localizes on their surface
    2021 ►
  15. Mesić Aner; Rogar Marija; Hudler Petra; Bilalović Nurija; Eminović Izet; Komel Radovan
    Genetic variations in AURORA cell cycle kinases are associated with glioblastoma multiforme
    2021 ►
  16. Zolotovskaia Marianna; Tkachev Victor; Sorokin Maxim; Garazha Andrew; Kim Ella; Rainer Kantelhardt Sven; Zottel Alja; Šamec Neja; Jovchevska Ivana
    Algorithmically deduced FREM2 molecular pathway is a potent grade and survival biomarker of human gliomas
    2021 ►
  17. Sorokin Maxim; Raevskiy Mikhail; Zottel Alja; Šamec Neja; Skoblar Vidmar Marija; Matjašič Alenka; Zupan Andrej; Mlakar Jernej; Suntsova Maria; Kuzmin Denis V.; Buzdin Anton A.; Jovchevska Ivana
    Large-scale transcriptomics-driven approach revealed overexpression of CRNDE as a poor survival prognosis biomarker in glioblastoma
    2021 ►
  18. Zottel Alja
    Analiza miR-9-5p, miR-124-3p, miR-21-5p, miR-138-5p in miR-1-3p in njihovih tarčnih genov v glioblastomskih celičnih linijah in majhnih zunajceličnih veziklih
    2021 ►
  19. Zottel Alja; Komel Radovan; Rozman Damjana; Lenassi Metka; Serša Gregor
    Ovrednotenje nanoteles proti izbranim proteinskim označevalcem glioblastoma in poskus njihove dostave z eksosomi
    [Evaluation of nanobodies against the selected protein biomarkers of glioblastoma and attempt of their delivery with exosomes]
    2021 ►
  20. Zottel Alja; Jovchevska Ivana; Šamec Neja; Komel Radovan
    Cytoskeletal proteins as glioblastoma biomarkers and targets for therapy
    2021 ►
  21. Lah Turnšek Tamara; Novak Metka; Pena Almidon Milagros A.; Marinelli Oliviero; Žvar Baškovič Barbara; Majc Bernarda; Mlinar Mateja; Bošnjak Roman; Breznik Barbara; Zomer Roby; Nabissi Massimo
    Cannabigerol is a potential therapeutic agent in a novel combined therapy for glioblastoma
    2021 ►
  22. Velnar Tomaž; Maver Uroš; Bošnjak Roman; Gradišnik Lidija
    The isolation of human glioblastoma cells
    2020 ►
  23. Jovchevska Ivana
    Carmelid [alpha]-FREM2 nanobody decreases proliferation of glioblastoma stem cells and localizes on their surface
    2020 ►
  24. Zaman Niyaz; Santhana Dass Serena; Parcq Persephone DU; Macmahon Suzanne; Gallagher Lewis; Thompson Lisa; Khorashad Jamshid S
    The KDR (VEGFR-2) genetic polymorphism Q472H and c-KIT polymorphism M541L are associated with more aggressive behaviour in astrocytic gliomas
    2020 ►
  25. Hoai Truong An; Sharmanska Viktoriia; Limbaeck Stanic Clara; Grech-Sollars Matthew
    Optimization of deep learning methods for visualization of tumor heterogeneity and brain tumor grading through digital pathology
    2020 ►
  26. Breznik Barbara; Limbaeck Stanic Clara; Porčnik Andrej; Blejec Andrej; Koprivnikar Krajnc Miha; Bošnjak Roman; Kos Janko; Noorden Cornelis J. F. van; Lah Turnšek Tamara
    Localization patterns of cathepsins K and X and their predictive value in glioblastoma
    2018 ►
  27. Zottel Alja; Šamec Neja; Kump Ana; Raspor Dall'Olio Lucija; Pužar Dominkuš Pia; Romih Rok; Hudoklin Samo; Mlakar Jernej; Nikitin Daniil; Sorokin Maxim; Buzdin Anton A.; Jovchevska Ivana; Komel Radovan
    Analysis of miR-9-5p, miR-124-3p, miR-21-5p, miR-138-5p, and miR-1-3p in glioblastoma cell lines and extracellular vesicles
    2020 ►
  28. Zottel Alja; Šamec Neja; Jovchevska Ivana; Kump Ana; Raspor Dall'Olio Lucija; Pužar Dominkuš Pia; Romih Rok; Hudoklin Samo; Mlakar Jernej; Knez Lea; Žužek Zala; Komel Radovan
    VIM, miR-124-3p in miR-9-5 prisotni v majhnih zunajceličnih veziklih so možni označevalci glioblastoma
    2020 ►
  29. Jovchevska Ivana; Šamec Neja; Zottel Alja; Kump Ana; Bolčina Lara; Krivec Eva; Muyldermans Serge; Šribar Jernej; Križaj Igor; Stojan Jure; Komel Radovan
    Ciljanje glioblastomskih matičnih celic s kamelidnim nanotelesom proti FREM2 proteinu
    2020 ►
  30. Clarke Matthew; Mackay Alan; Ismer Britta; Pickles Jessica C.; Tatevossian Ruth G.; Newman Scott; Bale Tejus A.; Stoler Iris; Izquierdo Elisa; Temelso Sara; Faganel Barbara; Popović Mara
    Infant high-grade gliomas comprise multiple subgroups characterized by novel targetable gene fusions and favorable outcomes
    2020 ►
  31. Zottel Alja; Šamec Neja; Videtič Paska Alja; Jovchevska Ivana
    Coding of glioblastoma progression and therapy resistance through long noncoding RNAs
    2020 ►
  32. Zottel Alja; Šamec Neja; Jovchevska Ivana; Kump Ana; Raspor Dall'Olio Lucija; Pužar Dominkuš Pia; Romih Rok; Hudoklin Samo; Komel Radovan
    TUFM and CRMP1 are significantly overexpressed in sEVs of glioblastoma stem cells
    2020 ►
  33. Jovchevska Ivana
    Next generation sequencing and machine learning technologies are painting the epigenetic portrait of glioblastoma
    2020 ►
  34. Vidak Marko; Jovchevska Ivana; Samec Tomi; Zottel Alja; Liović Mirjana; Rozman Damjana; Džeroski Sašo; Juvan Peter; Komel Radovan
    Meta-analysis and experimental validation identified FREM2 and SPRY1 as new glioblastoma marker candidates
    2019 ►
  35. Zottel Alja; Jovchevska Ivana; Šamec Neja; Mlakar Jernej; Šribar Jernej; Križaj Igor; Skoblar Vidmar Marija; Komel Radovan
    Anti-vimentin, anti-TUFM, anti-NAP1L1 and anti-DPYSL2 nanobodies display cytotoxic effect and reduce glioblastoma cell migration
    2020 ►
  36. Neves Oliveira Mona das; Breznik Barbara; Pillat Micheli M.; Pereira Ricardo L.; Ulrich Henning; Lah Turnšek Tamara
    Kinins in glioblastoma microenvironment
    2019 ►
  37. Zottel Alja; Jovchevska Ivana; Šamec Neja; Mlakar Jernej; Šribar Jernej; Križaj Igor; Skoblar Vidmar Marija; Komel Radovan
    Anti-TufM (Nb225) and anti-vimentin (Nb79) nanobodies are cytotoxic to glioblastoma cells and reduce their migration
    2020 ►
  38. Car Milan; Šteblaj Simona; Mitrović Goran; Dolenc-Stražar Zvezdana; Popović Mara
    Corticosteroid-induced immunodeficiency in a patient with gliomatosis cerebri
    2019 ►
  39. Šamec Neja; Zottel Alja; Videtič Paska Alja; Jovchevska Ivana
    Nanomedicine and immunotherapy
    2020 ►
  40. Velnar Tomaž; Bošnjak Roman; Bunc Gorazd; Maver Uroš; Gradišnik Lidija
    The isolation of human glioblastoma cells
    2019 ►
  41. Novak Metka; Koprivnikar Krajnc Miha; Hrastar Barbara; Breznik Barbara; Majc Bernarda; Hira Vashendriya V. V.; Mlinar Mateja; Rotter Ana; Porčnik Andrej; Bošnjak Roman; Mlakar Jernej; Lah Turnšek Tamara
    CCL5/CCR5 signaling is important for invasion of glioblastoma in its microenvironment
    2019 ►
  42. Jovchevska Ivana; Zottel Alja; Šamec Neja; Mlakar Jernej; Šribar Jernej; Sorokin Maxim; Nikitin Daniil; Buzdin Anton A.; Komel Radovan
    High FREM2 gene and protein expression are associated with favorable prognosis of IDH-WT glioblastomas
    2019 ►
  43. Zottel Alja; Jovchevska Ivana; Šamec Neja; Mlakar Jernej; Šribar Jernej; Križaj Igor; Skoblar Vidmar Marija; Komel Radovan
    Nanobodies anti-TUFM (Nb225) and anti-vimentin (Nb79) show cytotoxic and anti-migratory effect in glioblastoma cells
    2019 ►
  44. Komel Radovan; Šamec Neja; Jovchevska Ivana; Zottel Alja; Vidak Marko; Mlakar Jernej; Skoblar Vidmar Marija
    Can an advanced search for cancer stem cell biomarkers lead to efficient glioblastoma gene/immuno-therapy?
    2019 ►
  45. Matos Boštjan; Boštjančič Emanuela; Matjašič Alenka; Popović Mara; Glavač Damjan
    Dynamic expression of 11 miRNAs in 83 consecutive primary and corresponding recurrent glioblastoma: correlation to treatment, time to recurrence, overall survival and MGMT methylation status
    2019 ►
  46. Zottel Alja; Jovchevska Ivana; Šamec Neja; Mlakar Jernej; Šribar Jernej; Križaj Igor; Skoblar Vidmar Marija; Komel Radovan
    Nanobodies anti-TufM (Nb225) and anti-vimentin (Nb79) are cytotoxic to glioblastoma (stem) cells and reduce cell migration
    2019 ►
  47. Koprivnikar Krajnc Miha; Novak Metka; Pestell Richard G.; Lah Turnšek Tamara
    Cytokine CCL5 and receptor CCR5 axis in glioblastoma multiforme
    2019 ►
  48. Matjašič Alenka; Zupan Andrej; Boštjančič Emanuela; Pižem Jože; Popović Mara; Kolenc Danijela
    A novel PTPRZ1-ETV1 fusion in gliomas
    2019 ►
  49. Jovchevska Ivana; Zottel Alja; Šamec Neja; Mlakar Jernej; Sorokin Maxim; Nikitin Daniil; Buzdin Anton A.; Komel Radovan
    High FREM2 gene and protein expression are associated with favorable prognosis of IDH-WT glioblastomas
    2019 ►
  50. Zottel Alja; Jovchevska Ivana; Šamec Neja; Mlakar Jana; Križaj Igor; Skoblar Vidmar Marija; Komel Radovan
    Nanobodies NB79 (anti-vimentin), NB179 (anti- NAP1L1), NB225 (anti-TUFM) and NB314 (anti- DPYSL2) are cytotoxic and reduce migration of glioblastoma (stem) cells
    2019 ►
  51. Jovchevska Ivana; Šamec Neja; Zottel Alja; Mlakar Jana; Sorokin M; Buzdin Anton A.; Komel Radovan
    Increased FREM2 gene and protein expression is associated to glioblastoma malignant progression and recurrence
    2019 ►
  52. Zottel Alja; Videtič Paska Alja; Jovchevska Ivana
    Nanotechnology meets oncology
    2019 ►
  53. Kolenc Danijela; Jakovčević Antonia; Macan Marija; Žarković Kamelija
    The co-expression of 4-hydroxynonenal and prominin-1 in glioblastomas
    2011 ►
  54. Prunk Mateja; Perišić Milica; Sabotič Jerica; Švajger Urban; Kos Janko
    Increased cystatin F levels correlate with decreased cytotoxicity of cytotoxic T cells
    2019 ►
  55. Žarković Kamelija; Juric Gordana; Waeg Georg; Kolenc Danijela; Žarković Neven
    Immunohistochemical appearance of HNE-protein conjugates in human astrocytomas
    2005 ►
  56. Feigl Guenther C.; Heckl Stefan; Kullmann Marcel; Filip Zoltan; Decker Karlheinz; Klein Jan; Ernemann Ulrike; Tatagiba Marcos; Velnar Tomaž; Ritz Rainer
    Review of first clinical experiences with a 1.5 Tesla ceiling-mounted moveable intraoperative MRI system in Europe
    2019 ►
  57. Šimenc Janez; Jurič Damijana Mojca; Lipnik-Štangelj Metoda
    NADPH oxidase inhibitor VAS2870 prevents staurosporine-induced cell death in rat astrocytes
    2019 ►
  58. Matos Boštjan; Boštjančič Emanuela; Matjašič Alenka; Popović Mara; Glavač Damjan
    Dynamic expression of 11 miRNAs in 83 consecutive primary and corresponding recurrent glioblastoma
    2018 ►
  59. Jovchevska Ivana; Zottel Alja; Šamec Neja; Mlakar Jernej; Šribar Jernej; Križaj Igor; Muyldermans Serge; Buzdin Anton A.; Komel Radovan
    Nanobodies and OncoFinder
    2018 ►
  60. Vidak Marko; Komel Radovan; Debeljak Nataša; Serša Gregor; Lah Turnšek Tamara
    Analiza celičnih komunikacijskih omrežij potencialnih označevalcev matičnih celic multiformnega glioblastoma
    [Analysis of cell communication networks for potential markers of glioblastoma multiforme stem cells]
    2018 ►
  61. Jovchevska Ivana
    Genetic secrets of long-term glioblastoma survivors
    2018 ►
  62. Jovchevska Ivana; Zottel Alja; Šamec Neja; Mlakar Jernej; Muyldermans Serge; Buzdin Anton A.; Komel Radovan
    Combination of nanobody proteomics and OncoFinder bioinformatics in glioblastoma research and targeting
    2018 ►
  63. Zottel Alja; Šamec Neja; Vidak Marko; Jovchevska Ivana
    From basic glioblastoma proteomics to promising diagnostic and therapeutic tools
    2018 ►
  64. Šamec Neja; Komel Radovan; Čurin-Šerbec Vladka; Veranič Peter; Kos Janko
    Uporabnost nano-protiteles pri razvoju ciljanega zdravljenja glioblastoma
    [Implementation of nanobodies for the design of glioblastoma targeting therapy]
    2018 ►
  65. Smrdel Uroš; Skoblar Vidmar Marija; Smrdel Aleš
    Glioblastoma in patients over 70 years of age
    2018 ►
  66. Vidak Marko; Jovchevska Ivana; Šamec Neja; Zottel Alja; Liović Mirjana; Rozman Damjana; Džeroski Sašo; Juvan Peter; Komel Radovan
    Meta-analysis and experimental validation identified FREM2 and SPRY1 as new glioblastoma marker candidates
    2018 ►
  67. Jovchevska Ivana
    Sequencing the next generation of glioblastomas
    2018 ►
  68. Zupanec Neja; Jovchevska Ivana; Stojan Jure; Zottel Alja; Liović Mirjana; Myers Michael P.; Muyldermans Serge; Šribar Jernej; Križaj Igor; Komel Radovan
    Glioblastoma-specific anti-TUFM nanobody for in-vitro immunoimaging and cancer stem cell targeting
    2018 ►
  69. Georgakis Marios K.; Papathoma Paraskevi; Ryzhov Anton; Eser Sultan; Taraszkiewicz Łukasz; Sekerija Mario; Žagar Tina; Antunes Luis; Zborovskaya Anna A.; Bastos Joana
    Malignant central nervous system tumors among adolescents and young adults (15-39 years old) in 14 Southern-Eastern European registries and the US Surveillance, Epidemiology, and End Results program
    2017 ►
  70. Komel Radovan
    Novel approaches in looking for glioblastoma - specific protein markers, and targeting
    2017 ►
  71. Vidak Marko; Liović Mirjana; Jovchevska Ivana; Rozman Damjana; Džeroski Sašo; Komel Radovan
    Bioinformatic identification and experimental validation of new glioblastoma stem cell marker candidates
    2017 ►
  72. Zottel Alja; Zupanec Neja; Jovchevska Ivana; Šribar Jernej; Križaj Igor; Zadravec-Zaletel Lorna; Komel Radovan
    Evaluation of nanobodies against potential glioblastoma biomarkers
    2017 ►
  73. Breznik Barbara
    Niše tumorskih matičnih celic kot obetavne terapevtske tarče
    2017 ►
  74. Jovchevska Ivana; Zupanec Neja; Urlep Žiga; Vranič Andrej; Matos Boštjan; Limbäck-Stokin Clara; Muyldermans Serge; Myers Michael P.; Buzdin Anton A.; Petrov Ivan; Komel Radovan
    Differentially expressed proteins in glioblastoma multiforme identified with a nanobody-based anti-proteome approach and confirmed by OncoFinder as possible tumor-class predictive biomarker candidates
    2017 ►
  75. Vidak Marko; Liović Mirjana; Džeroski Sašo; Rozman Damjana; Komel Radovan
    Discovery of new glioblastoma stem cell marker candidates by analyzing mRNA microarray data from NCBI GEO database
    2017 ►
  76. Zupanec Neja; Jovchevska Ivana; Zottel Alja; Liović Mirjana; Myers Michael P.; Podergajs Neža; Muyldermans Serge; Komel Radovan
    Identification of an anti-T nanobody in VHH library and its cytotoxic effect on glioblastoma cells
    2017 ►
  77. Smrdel Uroš; Popović Mara; Zwitter Matjaž; Boštjančič Emanuela; Zupan Andrej; Kovač Viljem; Glavač Damjan; Bokal Drago; Jerebic Janja
    Long-term survival in glioblastoma: methyl guanine methyl transferase (MGMT) promoter methylation as independent favourable prognostic factor
    2016 ►
  78. Vidak Marko; Rozman Damjana; Liović Mirjana; Komel Radovan
    Search of new glioblastoma stem cell markers by comparing microarrays data from the NCBI geo database, and experimental validation of those markers in glioma cell lines
    2016 ►
  79. Zottel Alja; Jovchevska Ivana; Zupanec Neja; Komel Radovan
    Glioblastoma multiforme and nanobodies
    2016 ►
  80. Komel Radovan
    Functional analysis of proteomic biomarkers and targeting glioblastoma stem cells
    2016 ►
  81. Jovchevska Ivana; Zupanec Neja; Urlep Žiga; Vranič Andrej; Matos Boštjan; Limbäck-Stokin Clara; Muyldermans Serge; Myres Michael P.; Buzdin Anton A.; Petrov Ivan; Komel Radovan
    Nanobody-based approach for the selection of novel differentially expressed proteins in glioblastoma multiforme and their potential use as biomarkers for class prediction
    2016 ►
  82. Verbovšek Urška; Lah Turnšek Tamara; Noorden Cornelis J. F. van
    Cathepsin K as a potential tumor marker in glioblastoma multiforme
    2016 ►
  83. Vidak Marko; Rozman Damjana; Liović Mirjana; Komel Radovan
    Search of new glioblastoma stem cell markers by analysis of NCBI GEO datasets, and experimental validation of those markers in glioma cell lines
    2016 ►
  84. Komel Radovan
    Potential human glioblastoma cancer markers identified with nanobody-based reverse proteomic approach
    2016 ►
  85. Jovchevska Ivana
    Exploiting nanobodies in the search for protein markers of glioblastoma multiforms
    2015 ►
  86. Vittori Miloš; Breznik Barbara; Gredar Tajda; Hrovat Katja; Bizjak-Mali Lilijana; Lah Turnšek Tamara
    Imaging of human glioblastoma cells and their interactions with mesenchymal stem cells in the zebrafish (Danio rerio) embryonic brain
    2016 ►
  87. Bisdas Sotirios; Smrdel Uroš; Bajrović Fajko; Šurlan Popović Katarina
    Assessment of progression-free-survival in glioblastomas by intratreatment dynamic contrast-enhanced MRI
    2016 ►
  88. Motaln Helena; Schuchhardt Johannes; Stec Karol; Breznik Barbara; Ulrich Henning; Lah Turnšek Tamara
    Paradoxical role of mesenchymal stem cells in the glioblastoma microenvironment
    2014 ►
  89. Mesti Tanja; Ocvirk Janja
    Evaluation of the glioblastoma cell lines response to arsenic trioxide (As [sub] 2O [sub] 3) and bevacizumab according to the IDH1 mutation status
    [Odgovor glioblastomskih celičnih linij na arzenov trioksid (As [spodaj] 2O [spodaj] 3) in bevacizumab glede na prisotnost IDH1 mutacije]
    2015 ►
  90. Panjan Peter; Štrukelj Borut
    Razvoj genskega zdravljenja pri glioblastomu
    [Development of gene therapy for glioblastoma]
    2014 ►
  91. Matos Boštjan; Boštjančič Emanuela; Popović Mara; Glavač Damjan
    Dynamic of expression of eleven micrornas in recurrent glioblastoma before and after treatment with radiotherapy and chemotherapy
    2015 ►
  92. Vidak Marko; Rozman Damjana; Komel Radovan
    Effects of flavonoids from food and dietary supplements on glial and glioblastoma multiforme cells
    2015 ►
  93. Glavač Damjan
    The predictive value of MGMT promotor methylation in glioblastoma patients
    2015 ►
  94. Boštjančič Emanuela; Matos Boštjan; Popović Mara
    microRNA signatures in operable recurrent glioblastoma before and after treatment
    2015 ►
  95. Smrdel Uroš; Popović Mara; Zwitter Matjaž; Boštjančič Emanuela; Zupan Andrej; Kovač Viljem; Glavač Damjan; Bokal Drago; Jerebic Janja
    Long-term survival in glioblastoma
    2015 ►
  96. Vidak Marko; Jovčevska Ivana; Zupanec Neja; Komel Radovan
    Analysis of communication networks of glioblastoma stem cell markers
    2015 ►
  97. Zupanec Neja; Jovčevska Ivana; Liović Mirjana; Komel Radovan
    Localization and cytotoxicity of nanobodies directed against glioblastoma multiforme biomarkers
    2015 ►
  98. Mihalic Filip; Zupanec Neja; Jovčevska Ivana; Komel Radovan; Liović Mirjana
    Glioblastoma specific nanobodies
    2015 ►
  99. Komel Radovan
    TRIM28 and beta-actin as potential biomarkers for glioblastoma targeting
    2015 ►
  100. Vidak Marko; Jovčevska Ivana; Zupanec Neja; Komel Radovan
    Cell communication network analysis of glioblastoma stem cell marker candidates [beta]-actin, CD9, FTL, S100A9 and TRIM28
    2015 ►

1 101 201  


New search      Comments      Top of page Institute for Biostatistics and Medical Informatics